R. S. Rambo et al. / Tetrahedron: Asymmetry xxx (2015) xxx–xxx
5
chromatography separations were done by using silica gel Fluka,
100–200 Mesh. Solvents were purified by usual methods.13 Other
reagents were obtained from commercial source and used without
further purification. The organic extracts were dried over anhy-
drous sodium sulfate. Evaporation of solvent was performed under
reduced pressure. Brine refers to saturated solution of NaCl in
water at 25 °C.
as a white solid. Yield: 50%. Mp 193–196 °C. [
a
]
20 = ꢁ98 (c 1,
D
CH2Cl2). IR (FT-IR/ATR, cmꢁ1): 1517, 1656, 2960, 2980, 3320. 1H
NMR (300 MHz, CDCl3) d: 7.71 (m, 2H), 7.58 (m, 2H), 7.39 (m,
2H), 7.24 (m, 7H), 7.17 (m, 3H), 5.40 (br s, 1H), 4.84 (m, 1H),
3.81 (m, 1H), 3.17 (m, 2H), 2.91 (dd, 2H, J = 3.4 Hz, J = 13.6 Hz),
2.79 (dd, 2H, J = 8.5 Hz, J = 11.9 Hz), 2.09 (br s, 1H), 1.63 (br s,
1H), 1.43 (s, 3H), 0.97 (s, 3H). 13C NMR (CDCl3, 75.5 MHz) d:
172.1, 145.7, 144.9, 139.1, 129.1, 128.8, 128.3, 127.4, 126.6,
126.2, 125.8, 125.4, 80.9, 80.2, 67.6, 60.8, 59.4, 36.1, 30.3, 28.3.
HRMS calculated for [C27H30N2O2S+Na]+: 469.5935, obtained:
469.5940.
4.2. General procedure for the synthesis of catalysts 3a-c
In 150 mL two necked round-bottomed flask, the N-protected
thiazolidine 1a or 1b (15 mmol), anhydrous dichloromethane
(30 mL) and N-methylmorpholine (1.62 mL, 15 mmol) were added
under argon atmosphere at 0 °C. The solution was stirred for
30 min. then ethyl chloroformate (1.43 mL, 15 mmol) was added.
After 30 min. the aminoalcohol (15 mmol) was added and the
mixture was stirred for 24 h at rt. Then, the mixture was diluted
in dichloromethane (20 mL) and washed with 1 M NaOH and aque-
ous solution of NaCl. The organic layer was dried over Na2SO4 and
evaporated. The residue was dissolved in ethyl acetate (60 mL) and
a solution of 4.5 M HCl in ethyl acetate (54 mL) was added
dropwise at 0 °C. The suspension was stirred for 15 min. and then
the solvent was evaporated. The residue was dissolved in
dichloromethane and evaporated again. This procedure was
4.3. General procedure for organocatalytic asymmetric direct
aldol addition
A solution of a catalyst 3 in dry cyclic ketone (0.5 mL) was stir-
red at the temperature indicated in the tables, for around 2 h.
Aldehyde (1 mmol) was then slowly added and after addition of
brine (0.5 mL) the resulting mixture was stirred for the indicated
time. After that, the reaction mixture was treated with saturated
aqueous ammonium chloride solution (10 mL) and the whole mix-
ture was extracted with dichloromethane (3 ꢀ 20 mL). The organic
layer was dried over Na2SO4, and the solvent was removed under
vacuum. The crude mixture was purified by column chromatogra-
phy on silica gel with hexanes/ethyl acetate (80:20) being the
eluant. The enantiomeric excess (ee) was determined by HPLC
analysis using Chiracel OD-H or OJ-H and Chiralpak AD-H or AS-
H columns and the diastereomeric ratio was determined by 1H
NMR analysis.
repeated three times. The residue was then dissolved in
a
solution of CH2Cl2 1:1 H2O, cold to 0 °C and neutralized with
K2CO3. The organic layer was separated and the aqueous layer
washed with CH2Cl2 (3 ꢀ 50 mL). The combined organic extracts
were dried over Na2SO4 and evaporated. The residue was purified
with column chromatography or recrystallization to furnish the
product.
4.3.1. (S)-2-((R)-Hydroxy(phenyl)methyl)cyclohexanone 6a
This compound was obtained in a maximum yield of 66% with
ee = 99% and dr = >20:1. The enantiomeric excess was determined
by HPLC on Chiralcel OD-H (hexanes/2-propanol 90:10); 221 nm;
flow rate 0.5 mL/min; tR(major) = 9.38 min (S, R), tR(minor) = 12.48
4.2.1. (R)-N-((S)-1-Hydroxy-4-(methylthio)-1,1-diphenylbutan-
2-yl)thiazolidine-4-carboxamide 3a
This was prepared as per our general procedure to afford pro-
duct 3a. Recrystallization from CH2Cl2 furnished a white solid.
min (R, S). [a] [a]
20 = +18 (c 1, CHCl3) {lit.5 25 = +19 (c 1, CHCl3)}.
D D
Yield: 80%. Mp 152–154 °C. [
a
]
20 = ꢁ57 (c 1, CH2Cl2). IR (FT-IR/
1H NMR (300 MHz, CDCl3, d) 7.30 (5H, m), 4.79 (1H, d, J = 8.8 Hz),
4.05 (1H, s), 2.63 (1H, m), 2.49 (1H, m), 2.34 (1H, m), 2.06 (1H,
m), 1.62 (4H, m), 1.28 (1H, m).
D
ATR, cmꢁ1): 1515, 1651, 3324. 1H NMR (300 MHz, CDCl3) d: 7.55
(m, 4H), 7.44 (d, 1H, J = 9.2 Hz), 7.23 (m, 6H), 4.98 (m, 1H), 4.73
(br s, 1H), 3.98 (d, 1H, J = 10 Hz), 3.78 (dd, 1H, J = 4.8 Hz,
J = 7.3 Hz), 3.51 (d, 1H, J = 10 Hz), 2.97 (dd, 1H, J = 4.9 Hz,
J = 10.9 Hz), 2.81 (dd, 1H, J = 7.3 Hz, J = 10.8 Hz), 2.58 (m, 2H),
2.33 (br s, 1H), 1.95 (s, 3H), 1.84 (m, 1H). 13C NMR (75.5 MHz,
CDCl3) d: 172.1, 146.2, 144.1, 128.8, 128.1, 127.7, 127.3, 124.9,
81.2, 65.9, 56.1, 53.6, 35.1, 31.1, 28.2, 15.3. HRMS calculated for
[C21H26N2O2S2+Na]+: 425.5626, obtained: 425.5620.
4.3.2. (S)-2-((R)-Hydroxy(p-tolyl)methyl)cyclohexanone 6b
This compound was obtained in a maximum yield of 25% with
ee >99% and dr = 98:2. The enantiomeric excess was determined
by HPLC with chiral stationary phase: tR(major) = 25.27 min (S, R),
tR(minor) = 23.45 min (R, S).
[a]
D
[a]
25 = +17 (c 0.2, CHCl3) {lit.14
D
24 = +12.9 (c 0.17, CHCl3)}. 1H NMR (300 MHz, CDCl3) d 7.18–
7.02 (4H, m), 4.67 (1H, d, J = 8.8 Hz), 2.58–2.46 (1H, m), 2.45–
2.34 (1H, m), 2.34–2.17 (4H, m), 2.07–1.93 (1H, m), 1.77–1.63
(1H, m), 1.63–1.35 (3H, m), 1.30–1.12 (1H, m).
4.2.2. (R)-N-((R)-1-Hydroxy-3-mercapto-1,1-diphenylpropan-2-
yl)thiazolidine-4-carboxamide 3b
This was prepared as per our general procedure to afford
product 3b. Recrystallization from EtOH furnished
a
white
4.3.3. (S)-2-((R)-Hydroxy(4-methoxyphenyl)methyl)cyclohex-
anone 6c
solid. Yield: 65%. Mp 128–131 °C. [
a]
D
20 = ꢁ151 (c 1, CH2Cl2).
IR (FT-IR/ATR, cmꢁ1): 1522, 1655, 2554, 3334. 1H NMR
(300 MHz, CDCl3) d: 7.71 (m, 5H), 7.25 (m, 6H), 5.29 (br s,
2H), 4.01 (m, 1H), 3.76 (s, 2H), 3.08 (br s, 1H), 2.80 (m, 3H),
2.39 (br s, 1H). 13C NMR (CDCl3, 75.5 MHz) d: 172.1, 145.2,
144.1, 129.1, 128.9, 127.9, 125.5, 81.1, 66.1, 57.5, 53.4, 38.2,
35.1. HRMS calculated for [C19H22N2O2S2+Na]+: 397.5094,
obtained: 397.5090.
This compound was obtained in a maximum yield of 15% with
ee = 98% and dr = 89:11. The enantiomeric excess was determined
by HPLC with chiral stationary phase: tR(major) = 33.85 min (S, R),
tR(minor) = 30.60 min (R, S).
[a]
D
[a]
25 = +25 (c 1, CHCl3) {lit.5
D
25 = +30.5 (c 1.7, CHCl3)}. 1H NMR (300 MHz, CDCl3) d 7.17
(2H, d, J = 8.7 Hz), 6.81 (2H, d, J = 8.5 Hz), 4.67 (1H, d, J = 9.0 Hz),
3.87 (1H, br s), 3.73 (3H, s), 2.60–2.21 (3H, m), 2.09–1.92 (1H,
m), 1.83–1.38 (4H, m), 1.30–1.09 (1H, m).
4.2.3. (R)-N-((S)-1-Hydroxy-1,1,3-triphenylpropan-2-yl)-2,2-
dimethylthiazolidine-4-carboxamide 3c
This was prepared as per our general procedure to afford pro-
duct 3c. The residue was concentrated in vacuum and purified by
column chromatography with silica gel 230–400 Mesh with a mix-
ture of hexanes/ethyl acetate (1:1) as eluent to furnish the product
4.3.4. (S)-2-((R)-(4-Chlorophenyl)(hydroxy)methyl)cyclohex-
anone 6d
This compound was obtained in a maximum yield of 84% with
ee = 99% and dr = 96:4. The enantiomeric excess was determined
by HPLC with chiral stationary phase: tR(major) = 32.63 min (S, R),